Home › NCT07719582

Effectivity of P1821, a Novel Tongue Strengthening and Endurance Enhancing Speech Flow Exercise

Who can join

All ages · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* Can read and write
* Willing and able to follow the requirements of the protocol

Exclusion Criteria:

* Previously seen and treated by speech and language pathologist for dysphagia or dysarthria for non-head and neck cancer causes
* Medical instability, restlessness, or other factors that would compromise data acquisition

About the study

The P1821 initiative constitutes an innovative intervention specifically engineered to enhance tongue muscular strength and endurance. The primary objective of this research study is to ascertain whether the integration of a proactive tongue strengthening exercise regimen, utilizing a Non-Significant Risk (NSR) Device, contributes to an observable improvement in speech fluency.

What is being tested

• P1821 (device)

Sponsor: Dream Video LLC · Participants: 100 · Started: Nov 1, 2026

Contact the study team

• Matthew Quitto II · Phone: 917-342-2895

Official record on ClinicalTrials.gov — NCT07719582

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.